218 related articles for article (PubMed ID: 32317860)
1. Dexmedetomidine Protects against Ischemia and Reperfusion-Induced Kidney Injury in Rats.
Bao N; Dai D
Mediators Inflamm; 2020; 2020():2120971. PubMed ID: 32317860
[TBL] [Abstract][Full Text] [Related]
2. The effect of dexmedetomidine against oxidative and tubular damage induced by renal ischemia reperfusion in rats.
Cakir M; Polat A; Tekin S; Vardi N; Taslidere E; Rumeysa Duran Z; Tanbek K
Ren Fail; 2015 May; 37(4):704-8. PubMed ID: 25687385
[TBL] [Abstract][Full Text] [Related]
3. Dexmedetomidine protects against cisplatin-induced acute kidney injury in mice through regulating apoptosis and inflammation.
Liang H; Liu HZ; Wang HB; Zhong JY; Yang CX; Zhang B
Inflamm Res; 2017 May; 66(5):399-411. PubMed ID: 28224201
[TBL] [Abstract][Full Text] [Related]
4. [Effects of Dexmedetomidine on the levels of proinflammatory mediators IL-1βand TNF-α in pulmonary ischemia/reperfusion injury rats and the mechanisms].
Xiang BQ; He JB; Gao H; Luo ZY; Dai YY; Wang WT
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2017 May; 33(5):415-419. PubMed ID: 29926585
[TBL] [Abstract][Full Text] [Related]
5. Dexmedetomidine protects against renal ischemia and reperfusion injury by inhibiting the P38-MAPK/TXNIP signaling activation in streptozotocin induced diabetic rats.
Yeda X; Shaoqing L; Yayi H; Bo Z; Huaxin W; Hong C; Zhongyuan X
Acta Cir Bras; 2017 Jun; 32(6):429-439. PubMed ID: 28700004
[TBL] [Abstract][Full Text] [Related]
6. Dexmedetomidine (DEX) protects against hepatic ischemia/reperfusion (I/R) injury by suppressing inflammation and oxidative stress in NLRC5 deficient mice.
Chen Z; Ding T; Ma CG
Biochem Biophys Res Commun; 2017 Nov; 493(2):1143-1150. PubMed ID: 28784305
[TBL] [Abstract][Full Text] [Related]
7. Dexmedetomidine Preconditioning Protects Rats from Renal Ischemia-Reperfusion Injury Accompanied with Biphasic Changes of Nuclear Factor-Kappa B Signaling.
Bao N; Tang B; Wang J
J Immunol Res; 2020; 2020():3230490. PubMed ID: 32377532
[TBL] [Abstract][Full Text] [Related]
8. Renoprotective effects of dexmedetomidine against ischemia-reperfusion injury in streptozotocin-induced diabetic rats.
Kim SH; Jun JH; Oh JE; Shin EJ; Oh YJ; Choi YS
PLoS One; 2018; 13(8):e0198307. PubMed ID: 30114208
[TBL] [Abstract][Full Text] [Related]
9. Dexmedetomidine Alleviates Ischemia/Reperfusion-Associated Acute Kidney Injury by Enhancing Autophagic Activity
Zhou BY; Yang J; Luo RR; Sun YL; Zhang HT; Yang AX; Zhang GX
Front Biosci (Landmark Ed); 2023 Dec; 28(12):323. PubMed ID: 38179733
[TBL] [Abstract][Full Text] [Related]
10. Dexmedetomidine protects against ischemia-reperfusion injury in rat skeletal muscle.
Dong X; Xing Q; Li Y; Han X; Sun L
J Surg Res; 2014 Jan; 186(1):240-5. PubMed ID: 24007817
[TBL] [Abstract][Full Text] [Related]
11. Dexmedetomidine ameliorates renal ischemia reperfusion-mediated activation of the NLRP3 inflammasome in alveolar macrophages.
Chen Y; Huang Y; Xiong B; Luo H; Song X
Gene; 2020 Oct; 758():144973. PubMed ID: 32707303
[TBL] [Abstract][Full Text] [Related]
12. [Effect of dexmedetomidine on renal injury induced by lung ischemia/reperfusion in mice].
Xiang BQ; Gao H; Luo ZY; Fang ZX; Wang WT
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2017 Apr; 33(4):380-384. PubMed ID: 29926648
[TBL] [Abstract][Full Text] [Related]
13. Effects of dexmedetomidine on lipopolysaccharide-induced acute kidney injury in rats and mitochondrial function in cell culture.
Kiyonaga N; Moriyama T; Kanmura Y
Biomed Pharmacother; 2020 May; 125():109912. PubMed ID: 32014689
[TBL] [Abstract][Full Text] [Related]
14. Does remifentanil attenuate renal ischemia-reperfusion injury better than dexmedetomidine in rat kidney?
Erkılıç E; Kesimci E; Alaybeyoğlu F; Kılınç I; Tural R; Yazgan A; Gümüş T; Sepici Dinçel A; Dumlu EG; Kanbak O
Drug Des Devel Ther; 2017; 11():677-683. PubMed ID: 28331287
[TBL] [Abstract][Full Text] [Related]
15. α2-Adrenoceptor agonist dexmedetomidine protects septic acute kidney injury through increasing BMP-7 and inhibiting HDAC2 and HDAC5.
Hsing CH; Lin CF; So E; Sun DP; Chen TC; Li CF; Yeh CH
Am J Physiol Renal Physiol; 2012 Nov; 303(10):F1443-53. PubMed ID: 22933299
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of dexmedetomidine against diabetic hyperglycemia-exacerbated cerebral ischemia/reperfusion injury: An in vivo and in vitro study.
Chen L; Cao J; Cao D; Wang M; Xiang H; Yang Y; Ying T; Cong H
Life Sci; 2019 Oct; 235():116553. PubMed ID: 31185237
[TBL] [Abstract][Full Text] [Related]
17. Effects of dexmedetomidine on myocardial ischemia-reperfusion injury through PI3K-Akt-mTOR signaling pathway.
Zhang J; Jiang H; Liu DH; Wang GN
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6736-6743. PubMed ID: 31378917
[TBL] [Abstract][Full Text] [Related]
18. Perioperative acute kidney injury: The renoprotective effect and mechanism of dexmedetomidine.
Gao X; Wu Y
Biochem Biophys Res Commun; 2024 Feb; 695():149402. PubMed ID: 38159412
[TBL] [Abstract][Full Text] [Related]
19. Dexmedetomidine pretreatment inhibits cerebral ischemia/reperfusion‑induced neuroinflammation via activation of AMPK.
Wang Z; Zhou W; Dong H; Ma X; He Z
Mol Med Rep; 2018 Oct; 18(4):3957-3964. PubMed ID: 30106098
[TBL] [Abstract][Full Text] [Related]
20. Dexmedetomidine Protects Rat Liver against Ischemia-Reperfusion Injury Partly by the α2A-Adrenoceptor Subtype and the Mechanism Is Associated with the TLR4/NF-κB Pathway.
Wang Y; Wu S; Yu X; Zhou S; Ge M; Chi X; Cai J
Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
